BCAC News

Storage King turns pink for BCAC this October

Storage King NZ is turning pink this month to help support the Breast Cancer Aotearoa Coalition (BCAC) and the thousands of New Zealand women diagnosed with breast cancer each year.

BCAC's Ministry of Health visit

BCAC met with the Ministry of Health’s Cancer Team earlier this month for an update on issues raised in our Ministerial Briefing in March. We were pleased to hear that good progress has been made in breast reconstruction and the provision of fertility services. However, we remain concerned about inadequate funding for new medicines and inconsistencies among DHBs in offering lymphoedema services.

Lymphoedema patient register

The Australasian Lymphology Association has a grant from IBM to create a patient registry in New Zealand and Australia of those who have lymphoedema.

Merthyr Ruxton Exhibition to benefit BCAC

Artist Penny Kember, who paints under the name Merthyr Ruxton, will open a new exhibition this week at the Railway St Studios in Newmarket, Auckland.

Following her own diagnosis and recovery from breast cancer some years ago Penny has generously agreed to donate a portion of the sales proceeds to the Breast Cancer Aotearoa Coalition (BCAC).

We need your voice!

BCAC will meet the new Minister of Health, Jonathan Coleman, in March 2015 to highlight issues and concerns in the breast cancer community and we need your input to help identify the key priorities

Storage King continues to support BCAC

Following a successful campaign last year, Storage King throughout New Zealand is again supporting the Breast Cancer Aotearoa Coalition (BCAC) this October.

Living with metastatic breast cancer

Beyond the pink ribbons, the TV advertisements encouraging early detection and the fundraising events to raise money for breast cancer are those, both women and men, who a

BRCA gene patent unlikely to affect NZ patients

A recent Australian court ruling allowing US biotech company Myriad Genetics to continue to own the patent over the BRCA1 gene is not expected to have a significant impact on patients or research h

Pages